Double Helix Consulting expands
pharmafile | January 26, 2011 | Appointment | Sales and Marketing |Â Â Clara Loveman, Double Helix, Dr Clive Whitcher, Dr Laurence Wild, appointment, sales and marketingÂ
Double Helix Consulting has appointed three new executives to its growing global team – Clara Loveman, Dr Clive Whitcher and Dr Laurence Wild (pictured).
Clara joins Double Helix from NICE, where she helped set up the Patient Access Schemes Liaison Unit. As part of her role as technical lead, Clara reviewed submissions from pharmaceutical companies and advised the Department of Health on the viability of proposed patient access schemes.
She was also involved in the drafting of scopes for the Technology Appraisals programme, identifying relevant comparators, subgroups and outcomes.
Market access consultant Clive brings a mix of experience in strategic pricing and reimbursement, market access strategy development and industrial biotechnology research from previous experience in both consulting and the research industry itself.
Laurence brings with him extensive knowledge of global pricing and reimbursement issues and has having worked on a number of therapy areas including COPD, Crohn’s disease, nephrology and oncology.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






